Literature DB >> 962644

Cervical spondylotic radiculopathy and myelopathy. A long-term follow-up study.

F K Gregorius, T Estrin, P H Crandall.   

Abstract

The natural history of cervical spondylotic myelopathy in a series of 55 patients resulted in a moderate to severe disability during a mean period of 45 months. Results of operation for myelopathy indicated improvement in one group that was maintained for a mean of 85 months. In another group, progressive worsening occurred after operation, or late worsening occurred, in some instances as long as 8 to 12 years after improvement and plateau. Patients with cervical spondylotic radiculopathy tended to be separated from those with myelopathy with respect to presentation, symptom complex, and operative result. Results of operation for radiculopathy were consistently good. A worsened disability postoperatively for patients with cervical spondylotic myelopathy was associated with the preoperative symptom of sphincter disturbance and the sign of lower extremity weakness. Change in hand movement after operation for myelopathy and change in distance walking ability were not correlated with numerous preoperative factors. A trend of improvement in disability following anterior interbody fusion and a tendency to worsen in disability following all varities of laminectomy were significant.

Entities:  

Mesh:

Year:  1976        PMID: 962644     DOI: 10.1001/archneur.1976.00500090024005

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  17 in total

1.  Anterior microsurgical approach for degenerative cervical disc disease.

Authors:  R D Klaiber; K von Ammon; A C Sarioglu
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

Review 2.  Cervical laminectomy and instrumented lateral mass fusion: techniques, pearls and pitfalls.

Authors:  Michael Mayer; Oliver Meier; Alexander Auffarth; Heiko Koller
Journal:  Eur Spine J       Date:  2013-05-29       Impact factor: 3.134

Review 3.  Predictors of outcome in patients with degenerative cervical spondylotic myelopathy undergoing surgical treatment: results of a systematic review.

Authors:  Lindsay A Tetreault; Alina Karpova; Michael G Fehlings
Journal:  Eur Spine J       Date:  2013-02-06       Impact factor: 3.134

4.  Clinical long-term results of anterior discectomy without fusion for treatment of cervical radiculopathy and myelopathy. A follow-up of 164 cases.

Authors:  H Bertalanffy; H R Eggert
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

5.  Effects of surgery on cervical spondylotic myelopathy.

Authors:  J Wiberg
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

Review 6.  Cervical spondylosis. An update.

Authors:  B M McCormack; P R Weinstein
Journal:  West J Med       Date:  1996 Jul-Aug

7.  Post-laminectomy kyphosis in patients with cervical ossification of the posterior longitudinal ligament : does it cause neurological deterioration?

Authors:  Won-Sang Cho; Chun Kee Chung; Tae-Ahn Jahng; Hyun Jib Kim
Journal:  J Korean Neurosurg Soc       Date:  2008-06-20

8.  A comparative study of the treatment of cervical spondylotic myeloradiculopathy. Experience with 50 cases treated by means of extensive laminectomy, foraminotomy, and excision of osteophytes during the past 10 years.

Authors:  J A Epstein; Y Janin; R Carras; L S Lavine
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

9.  Treatment of cervical disc disease using Cloward's technique. III. Evaluation of cervical spondylotic myelopathy in 138 cases.

Authors:  L Wohlert; M Buhl; E F Eriksen; K Fode; A Klaerke; L Krøyer; H Lindeberg; C B Madsen; P Strange; J O Espersen
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

10.  The significance of preoperative radiological examinations in patients treated with Cloward's operation.

Authors:  O F Petersen; M Buhl; E F Eriksen; K Fode; A Klaerke; L Krøyer; H Lindeberg; C B Madsen; T Miletic; P Strange
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.